Susquehanna International Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.3M | Buy |
|
|||||
|
2025
Q2 | $715K | Sell |
|
|||||
|
2025
Q1 | $438K | Buy |
|
|||||
|
2024
Q4 | $407K | Buy |
|
|||||
|
2024
Q3 | $137K | Sell |
|
|||||
|
2024
Q2 | $192K | Buy |
|
|||||
|
2024
Q1 | $26K | Sell |
|
|||||
|
2023
Q4 | $639K | Buy |
|
|||||
|
2023
Q3 | $358K | Sell |
|
|||||
|
2023
Q2 | $768K | Buy |
|
|||||
|
2023
Q1 | $130K | Buy |
|
|||||
|
2022
Q4 | $93.3K | Sell |
|
|||||
|
2022
Q3 | $190K | Sell |
|
|||||
|
2022
Q2 | $175K | Sell |
|
|||||
|
2022
Q1 | $242K | Sell |
|
|||||
|
2021
Q4 | $535K | Buy |
|
|||||
|
2021
Q3 | $632K | Buy |
|
|||||
|
2021
Q2 | $182K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $307K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $113K | Buy |
|
|||||
|
2020
Q1 | $37K | Sell |
|
|||||
|
2019
Q4 | $247K | Buy |
|
|||||
|
2019
Q3 | $58K | Sell |
|
|||||
|
2019
Q2 | $202K | Sell |
|
|||||
|
2019
Q1 | $707K | Buy |
|
|||||
|
2018
Q4 | $647K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $406K | Buy |
|
|||||
|
2018
Q1 | $173K | Sell |
|
|||||
|
2017
Q4 | $538K | Buy |
|
|||||
|
2017
Q3 | $554K | Sell |
|
|||||
|
2017
Q2 | $6.99M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $3.71M | Buy |
|
|||||
|
2016
Q3 | $2.09M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $363K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1M | Buy |
|
|||||
|
2015
Q2 | $85K | Buy |
|
|||||
|
2015
Q1 | $11K | Sell |
|
|||||
|
2014
Q4 | $218K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $199K | Buy |
|
|||||
|
2014
Q1 | $181K | Sell |
|
|||||
|
2013
Q4 | $193K | Buy |
|
|||||
|
2013
Q3 | $245K | Buy |
|
|||||
|
2013
Q2 | $37K | Buy |
|